Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years

Estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2) are the mainstay of breast cancer management, and their prevalence rates vary among different populations possibly related to ethnic/genetic and/or socioeconomic status. In a previous study co...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsughayer, Anas M., Dabbagh, Tamara Z., Abdel-Razeq, Rashid H., Al-Jussani, Ghada N., Alhassoon, Salam, Sughayer, Maher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302262/
https://www.ncbi.nlm.nih.gov/pubmed/35436143
http://dx.doi.org/10.1200/GO.21.00359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302262/
https://www.ncbi.nlm.nih.gov/pubmed/35436143
http://dx.doi.org/10.1200/GO.21.00359

Ejemplares similares